Domain swapping of CD4 upon dimerization

Proteins: Structure, Function and Genetics

Volumn 57, Issue 1, 2004, Pages 205-212

  Sanejouand, Yves Henri ^a  

^a Laboratoire de Physique UMR CNRS ENSL   (France)

Author keywords

CD2; Crystallographic neighbor; Disulfide bond; Disulfide exchange; Immunoglobulin domain; Molecular dynamics; MT151; Optimization

Indexed keywords

CD4 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY;

ARTICLE; BINDING SITE; CELL SURFACE; CONFORMATIONAL TRANSITION; CRYSTALLOGRAPHY; DIMERIZATION; DISULFIDE BOND; ENERGY TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CRYSTALLOGRAPHY; DISULFIDES; EPITOPES; HUMANS; MODELS, CHEMICAL; MODELS, MOLECULAR; MULTIPROTEIN COMPLEXES; PROTEIN STRUCTURE, TERTIARY; RIBONUCLEASE, PANCREATIC; THERMODYNAMICS;

EID: 4444358269     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.20197     Document Type: Article

References (38)

1. Sattentau Q, Dalgleish A, Weiss R, Beverley P. Epitopes of the CD4 antigen and HIV infection. Science 1986;234:1120-1123.
2. Clayton L, Hussey R, Steinbrich R, Ramachandran H, Husain Y, Reinherz E. Substitution of murine for human CD4 residues identifies amino acids critical for HIV-Gp120 binding. Nature 1988;335:363-366.
3. Mizukami T, Fuerst T, Berger E, Moss B. Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis. Proc Natl Acad Sci USA 1988;85:9273-9277.
4. Jameson B, Rao P, Kong L, Hahn B, Shaw G, Hood L, Kent S. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science 1988;240:1335-1339.
5. Ashkenazi A, Presta L, Marsters S, Camerato T, Rosenthal K, Fendly B, Capon D. Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. Proc Natl Acad Sci USA 1990;87:7150-7154.
6. Lynch G, Sloane A, Raso V, Lai A, Cunningham A. Direct evidence for native CD4 oligomers in lymphoid and monocytoid cells. Eur J Immunol 1999;29:2590-2602.
7. Matthias L, Yam P, Jiang X, Vandegraaff N, Li P, Poumbourios P, Donoghue N, Hogg P. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol 2002;3(8):727-732.
8. Wang J, Yan Y, Garret T, Liu J, Rodgers D, Garlick R, Tarr G, Husain Y, Reinherz E, Harrison S. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 1990;348:411-418.
9. Ryu S, Kwong P, Truneh A, Porter T, Arthos J, Rosenberg M, Dai X, Xuong N, Axel R, Sweet R, Hendrickson W. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 1990;348:419-426.
10. Rauk A. Chiroptical properties of disulfides-ab initio studies of dihydrogen disulfide and dimethyl disulfide. J Am Chem Soc 1984;106(22):6517- 6524.
11. Katz B, Kossiakoff A. The crystallographically determined structures of atypical strained disulfides engineered into subtilisin. J Biol Chem 1986;261(33):15480-15485.
12. Murray A, Lewis S, Barclay A, Brady R. One sequence, two folds: a metastable structure of CD2. Proc Natl Acad Sci USA 1995;92:7337-7341.
13. Liu Y, Eisenberg D. 3D domain swapping: as domains continue to swap. Protein Sci 2002;11:1285-1299.
14. Bennett M, Choe S, Eisenberg D. Domain swapping: entangling alliances between proteins. Proc Natl Acad Sci USA 1994;91(8): 3127-3131.
15. Knaus K, Morillas M, Swietnicki W, Malone M, Surewicz W, Yee V. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 2001;8(9):770-774.
16. Bodian D, Jones E, Harlos K, Stuart D, Davis S. Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 Å resolution. Structure 1994;2(8):755-766.
17. Kwong P, Wyatt R, Robinson J, Sweet R, Sodroski J, Hendrickson W. Structure of an HIV Gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393:648-659.
18. Wang J, Meijers R, Xiong Y, Liu J, Sakihama T, Zhang R, Joachimiak A, Reinherz E. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci USA 2001;98(19):10799-10804.
19. http://www.cmbi.kun.nl/gv/servers/WIWWWI.
20. Humphrey W, Dalke A, Schulten K. VMD-visual molecular dynamics. J Molec Graphics 1996;14:33-38.
21. Kraulis P. Molscript: a program to produce both detailed and schematic plots of protein structures. J Appl Cryst 1991;24:946-950.
22. Brooks B, Bruccoleri R, Olafson B, States D, Swaminathan S, Karplus M. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comp Chem 1983;4:187-217.
23. Lazaridis T, Karplus M. Effective energy function for proteins in solution. Proteins 1999;35(2):133-152.
24. Seok C, Rosen J, Chodera J, Dill K. MOPED: method for optimizing physical energy parameters using decoys. J Comput Chem 2003;24(1):89-97.
25. Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, Jaskolski M. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Str Biol 2001;8(4):316-320.
26. Liu Y, Hart P, Schlunegger M, Eisenberg D. The crystal structure of a 3D domain-swapped dimer of RNase A at a 2.1 Å resolution. Proc Natl Acad Sci USA 1998;95(7):3437-3442.
27. Liu Y, G G, Libonati M, Eisenberg D. A domain-swapped RNAse A dimer with implications for amyloid formation. Nat Str Biol 2001;8(3):211-214.
28. Sanejouand YH. Normal-mode analysis suggests important flexibility between the two N-terminal domains of CD4 and supports the hypothesis of a conformational change in CD4 upon HIV binding. Prot Engin 1996;9(8):671-677.
29. Sanejouand YH. Rôle du changement de conformation du CD4 lors de la fusion VIH/cellule. C R Acad Sci Paris, Sciences de la vie 1997;320:163-170.
30. Peterson A, Seed B. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 1988;54:65-72.
31. Burkly L, Olson D, Shapiro R, Winkler G, Rosa J, Thomas D, Williams C, Chisholm P. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody: dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J Immunol 1992;149(5):1779-1787.
32. Moore J, Sattentau Q, Klasse P, Burkly L. A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells. J Virol 1992;66(8):4784-4793.
33. Wu H, Kwong P, Hendrickson W. Dimeric association and segmental variability in the structure of human CD4. Nature 1997;387:527-530.
34. Healey D, Dianda L, Moore J, McDougal J, Moore M, Estess P, Buck D, Kwong P, Beverley P, Sattentau Q. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J Exp Med 1990;172(4):1233-1242.
35. Bachelder R, Bilancieri J, Lin W, Letvin N. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4. J Virology 1995;69(9):5734-5742.
36. Yachou A, Sekaly R. Binding of soluble recombinant HIV envelope glycoprotein, rGp120, induces conformational changes in the cellular membrane-anchored CD4 molecule. Biochem Biophys Res Commun 1999;265(2):428-433.
37. Murray J, Hu Q, Navenot J, Peiper S. Role of CD4 hinge region in Gp120 utilization by immunoglobulin domain 1. Biochem Biophys Res Commun 2002;292(2):449-455.
38. Kelley B, Chang L, Bewley C. Engineering an obligate domain-swapped dimer of cyanovirin-N with enhanced anti-HIV activity. J Am Chem Soc 2002;124(13):3210-3211.